1. Home
  2. Antimicrobial resistance surveillance in Europe 2013 data

Antimicrobial resistance surveillance in Europe 2013 data

Data
Period: 01 Jan 2013 - 31 Dec 2013

The antimicrobial resistance surveillance in Europe 2013 report presents data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci. This data is available to download in the zip file below.

Download

Antimicrobial resistance surveillance in Europe 2013, downloadable data - EN - [ZIP-18.17 MB]
Antibiotic resistance in the EU 2013 - summary - EN - [PDF-683.53 KB]

The above zip folder contains the following tables and maps (available as Microsoft Excel files (.xlsx) and as images (.png)).

Escherichia coli

  • Total number of invasive isolates tested (N) and percentage resistant to aminopenicillins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with resistance to fluoroquinolones, by country, EU/EEA countries, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to third-generation cephalosporins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to third-generation cephalosporins, by country, EU/EEA, 2013
  • Number of reporting laboratories, total numbers of invasive isolates resistant to third-generation cephalosporins (3GCREC) and percentage of these isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by the participating laboratories, EU/EEA countries, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to carbapenems, by country, EU/EEA, 2013
  • Total number of isolates tested (N) and percentage combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with combined resistance to third-generation cephlosporins, fluoroquinolone and aminoglycosides, by country, EU/EEA, 2013

Klebsiella pneumoniae

  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to fluoroquinolones, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to third-generation cephalosporins (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to third-generation cephalosporins, by country, EU/EEA, 2013
  • Number of invasive isolates resistant to third-generation cephalosporins (3GCRKP) and percentage of these isolates positive for extended-spectrum beta-lactamase (ESBL), as ascertained by participating laboratories, by country, EU/EEA countries, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to carbapenems, by country, EU/EEA, 2013
  • Total number of isolates tested (N) and percentage of combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with combined resistance to fluoroquinolones, third-generation cephalosporins and carbapenems, by country, EU/EEA, 2013

Pseudomonas auroginosa

  • Total number of invasive isolates tested (N) and percentage resistant to piperacillin (+ tazobactam) (%R), including 95% confidence intervals (95%CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to piperacillin+tazobactam, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to fluoroquinolones, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to ceftazidime (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to ceftazidime, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to carbpenems, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) with combined resistance (resistance to three or more antimicrobial groups among piperacillin (+ tazobactam), ceftazidime, fluoroquinolones, aminoglycosides and carbapenems) including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with combined resistance (resistance to three or more antimicrobial classes among piperacillin(+tazobactam), ceftazidime, fluoroquinolones, aminoglycosides and carbapenems), by country, EU/EEA, 2013

Acinetobacter spp

  • Total number of invasive isolates tested (N) and percentage resistant to fluoroquinolones (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates resistant to fluoroquinolones, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to aminoglycosides (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates resistant to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to carbapenems (%R), including 95% confidence intervals (95% CI), EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates resistant to carbapenems, by country, EU/EEA, 2013
  • Total number of isolates tested (N) and percentage combined resistance to fluoroquinolones, aminoglycosides and carbapenems (%R), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2012-2013
  • Percentage (%) of invasive isolates with combined resistance to fluoroquinolones, aminoglycosides and carbapenems , by country, EU/EEA, 2013

Streptococcus pneumoniae

  • Total number of tested isolates (N) and percentages non-susceptible to penicillin (%IR), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013
  • Total number of tested isolates (N) and percentages non-susceptible to macrolides (%IR), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates non-susceptible to macrolides, by country, EU/EEA, 2013
  • Total number of tested isolates (N) and percentages non-susceptible to penicillins and macrolides (%IR), including 95% confidence intervals (95% CI), by country, EU/EEA countries, 2010-2013

Staphylococcus aureus

  • Total number of invasive isolates tested (N) and percentage resistant to meticillin (MRSA) including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to meticillin (MRSA), by country, EU/EEA, 2013

Enterococci

  • Total number of invasive isolates tested (N) and percentage with high-level resistance to aminoglycosides including 95% confidence intervals (95% CI), EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates with high-level resistance to aminoglycosides, by country, EU/EEA, 2013
  • Total number of invasive isolates tested (N) and percentage resistant to vancomycin, including 95% confidence intervals (95% CI) EU/EEA countries, 2010-2013
  • Percentage (%) of invasive isolates resistant to vancomycin, by country, EU/EEA, 2013

Related publications